2023 Technology Showcase

September 6, 2023 | 10:00 AM – 4:30 PM

Frederick National Laboratory Advanced Technology Research Facility Frederick, MD

Join us on September 6, 2023, for 2023 Technology Showcase, the annual event highlighting how potential industry partners can work with the NCI and Frederick National Laboratory (FNL).

Next steps

If you are interested in learning about any of the opportunities shared at the 2023 Technology Showcase, please reach out to us:

NCITechTransfer@mail.nih.gov
FNL - PDO@nih.gov

Event Overview

Free hybrid event.
Features NCI and FNL inventors highlighting technologies for commercialization and/or collaboration.
Showcases NCI and FNL programmatic leaders sharing opportunities to collaborate.
Explains partnering with the NCI and the FNL including the company perspective.
Includes panel sessions featuring collaboration success stories and topics relevant to commercializing biomedical technology.
Features a Lightning Pitch Competition followed by a Poster Session that highlights NIH technologies for co-development and/or licensing — presented by the NCI Technology Transfer Ambassadors Program.
Who should attend? Great opportunity for companies, investors, entrepreneurs, technology scouts looking for technologies to commercialize and all biotech stakeholders.

The event will conclude with an independently sponsored networking event nearby (no resources of the Department of Health and Human Services are involved).

Event Agenda

Program Schedule

Topics and Events

10:00 a.m.

Onsite check-in; Networking and coffee; Login online

11:00 - 11:10 a.m.

Welcome
Leonard Freedman, Ph.D., Chief Scientific Officer, Frederick National Laboratory for Cancer Research
Michael O'Connor, Mayor, City of Frederick
Jessica Fitzwater, County Executive, Frederick County, MD
Michael Salgaller, Ph.D., Unit Supervisor, NCI Technology Transfer Center

11:10 - 11:25 a.m.

Keynote Address

Thomas Misteli, Ph.D.
Director
NCI Center for Cancer Research

11:25 - 11:30 a.m.

Voice of the Patient / Patient Advocate

Jamie Troil Goldfarb

11:30 a.m. - 12:30 p.m.

NCI and Frederick National Laboratory Programmatic Presentations
Session features four, 10 - 14-minute presentations highlighting opportunities to collaborate with various laboratories and programs at NCI and FNL.

Moderator: Michael Salgaller, NCI TTC

Marina Dobrovolskaia, Ph.D., M.B.A., P.M.P., Laboratory Co-Director, Director of Operations, Nanotechnology Characterization Laboratory, FNLCR
Tanja Grkovic, Ph.D., Staff Scientist, Natural Products Branch, NCI
Mark Gilbert, M.D., Chief, Neuro-Oncology Branch, Center for Cancer Research, NCI
Jana Ognjenovic, Ph.D., Senior Scientist and Group Leader Advanced Cryo-EM Technology & Thomas Edwards, Ph.D., Senior Scientist and Group Leader National Cryo-EM Facility, FNL

12:35 - 12:50 p.m.

Lightning Pitch Competition

Introduction: Laura Prestia, Ph.D., Senior Innovation Manager, Technology Transfer Center, NCI

Presenters will deliver one-minute technology pitches. Presenters include representatives from the Technology Transfer Ambassadors Program (TTAP), NCI TTC, NCI Transition to Industry Fellowship (T2I) and the Johns Hopkins University (Discovery to Market Course).

Presenters and Affiliation	Poster Titles and Inventors
1. Ian McClain-Caldwell TTAP Ambassador	"Human monoclonal antibody to pathogen associated carbohydrate, deacetylated-PNAG" Lead Inventors: Jeff Gildersleeve, Ph.D., NCI CCR and J. Sebastian Temme, Ph.D.
2. Kaitlin Abrantes TTAP Ambassador	“The Untargeted Subunit of SARS-CoV-2” Lead inventor: Mitchell Ho, Ph.D., NCI CCR
3. Lucia Bettedi, Ph.D. TTAP Ambassador	"Immunosuppressive Interleukin 35 And Interleukin 27- Producing Exosomes As A Therapeutic Treatment" Lead inventor: Charles Egwuagu, Ph.D., National Eye Institute (NEI)
4. Roshini Traynor, TTAP Ambassador	"New T-Cell Immunotherapy that Targets Aggressive Epithelial Tumors" Inventors: Christian S. Hinrichs, M.D., Rutgers Cancer Institute of New Jersey (formerly NCI CCR) and Sanja Stevanović, Kite Pharma (formerly NCI)
5. Tuan Nguyen, Ph.D. TTAP Ambassador	"Novel Reusable Single-Cell Methods for High-Throughput Multi-Omics Analyses" Lead inventor: Hidetaka Ohnuki, Ph.D., NCI CCR
6. Zhaoyuan Gong, Ph.D. TTAP Ambassador	"La Protein as a Novel Regulator of Osteoclastogenesis" Inventors: Leonid V Chernomordik, Ph.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Evgenia Leikina, DVM, NICHD; Jarred M Whitlock, Ph.D., NICHD
7. Veronica Mendoza-Reinoso, Ph.D. NCI TTC Fellow	"Cyclic Peptides as Non-Hormonal Male Contraceptive Agents" Inventors: Maria L Dufau, M.D., Ph.D., NICHD, Murugananth Kumar Raju, Ph.D., NICHD, Raghuveer Kavarthapu, Ph.D., NICHD, Sergio A Hassan, Ph.D. National Institute of Allergy and Infectious Diseases (NIAID)
8. Alexandra Rech, M.B.A. Johns Hopkins University	"Enhanced Cancer Chemotherapy Using the Bioactive Peptide Recifin And Its Analogues" Inventors: Barry O'Keefe, Ph.D., NCI CCR; Lauren Haugh Krumpe, M.S., FNLCR; Yyes Pommier, M.D., Ph.D., NCI CCR; Christopher Marchand, Ph.D., NCI; Brice Wilson, Ph.D., NCI; Christina Schroeder, Ph.D., NCI; Johan Rosengren, Ph.D., University of Australia
9. Andrew Sinkoe, Ph.D. Transition to Industry Fellow (T2I)	"Method for HLA LOH Detection in Liquid Biopsies" Inventors: Andrew Sinkoe, Ph.D., NCI; Cem Sievers, Ph.D., NICHD; James Gulley, M.D., Ph.D., NCI CCR
10. Julian Burks, Ph.D. T2I Fellow (virtual presenter)	"PLS-a-GalCer: A Novel Targeted Glycolipid Therapy for Solid Tumors" Inventors: Julian Burks, Ph.D., NCI CCR, Jay Berzofsky, M.D., Ph.D., NCI CCR, Stephan Stern, Ph.D., D.A.B.T., FNL, David Stevens, Ph.D., NCI
11. Zehra Sherwani, Ph.D. NCI TTC Fellow (virtual presenter)	"Use of the TP5 Peptide for the Treatment of Cancer" Inventors: Zhengping Zhuang, M.D., Ph.D., NCI CCR; Emeline Tabouret, M.D., Ph.D., NCI; Herui Wang, Ph.D., NCI; Harish Pant, Ph.D., National Institute of Neurological Disorders and Stroke (NINDS); Niranjana Amin, Ph.D., NINDS
12. Todd Testerman, Ph.D. NCI TTC Fellow (virtual presenter)	"Furoquinolinedione Derivatives as TDP2 Inhibitors for Treating Cancer" Lead inventors: Yves Pommier, M.D., Ph.D., NCI CCR; Christophe Marchand, Ph.D., NCI; Linkun An

12:50 - 1:35 p.m.

Lunch, Networking, Poster Session

1:40 - 2:40 p.m.

Technology Presentations

Moderator: Amanda Corbel, M.S., Partnership Alliance Manager, FNL

"Polymeric Delivery Platform for Therapeutics," Stephan T. Stern, Ph.D., D.A.B.T., Laboratory Co-Director, Director of Research and Development, Nanotechnology Characterization Laboratory, FNL
AIDS and Cancer Virus Program Tissue Analysis Technical Services, Claire Deleage, Ph.D., Scientist, AIDS and Cancer Virus Program, FNL
"Cell Radiolabeling with Acoustophoresis Cell Washing," Stephen Adler, Ph.D., Molecular Imaging Program, Clinical Research Directorate, FNL
"EGFRvIII Antibodies for the Treatment of Human Cancer," David Fitzgerald, Ph.D., Senior Investigator, Laboratory of Molecular Biology, Center for Cancer Research, NCI

2:45 - 3:35 p.m.

Panel Sessions, Part One
Attendees choose which panel to attend

1. How to Tap into Resources and Work with the Frederick National Laboratory
Moderator: Vladimir Popov, Ph.D., M.B.A., Chief Innovation Officer, Center for Innovation and Strategic Partnerships, FNL

Serguei Kozlov, Ph.D., M.B.A., P.M.P., Principal Scientist, Preclinical Technology and Optimization Team Leader, Center for Advanced Preclinical Research, FNL
Larry H. Matherly, Ph.D., Eunice and Milton Ring Endowed Chair for Cancer Research, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine

2. Government Sources of Support

Moderator: Daryll Sampey, Ph.D., President & CEO, BioFactura

Matt McMahon, Ph.D., Director, NIH Small Business Education and Entrepreneurial Development (SEED)
Katherine Hill Ritchie, M.B.A. Senior Director, Venture Funds, TEDCO
Ulyana Desiderio, Ph.D., Director, Life Sciences, Maryland Department of Commerce
Paul Zielinski, M.S., Executive Director, Federal Laboratory Consortium

3:40 - 4:30 p.m.

Panel Sessions, Part Two
Attendees choose which panel to attend

3. Traditional and Foundation Sources of Support

Moderator: Tom Thomson, Chairman of the Management Committee, Venture Mentoring Service, Maryland Tech Council

Alfred Slanetz, Ph.D., Board Chair, National Foundation for Cancer Research
Bret Schreiber, M.B.A., Vice President, Fulton Bank
Steve Wolpe, Ph.D., Entrepreneur-in-Residence, BioHealth Innovation
Tanisha Jackson, Ph.D., Scientific Program Director, Melanoma Research Alliance

4. How to Work with the NCI

Moderator: Whitney Hastings, Ph.D., Senior Technology Transfer Manager, NCI TTC; Chair, Federal Laboratory Consortium

Michael Pollack, Ph.D., Unit Supervisor, NCI TTC
James Hodge, Ph.D., M.B.A., Senior Investigator, NCI, Center for Cancer Research, Center for Immuno-Oncology
Gayatri Varma., Ph.D., Executive Director, Head of Transaction, Oncology Business Development & Licensing, AstraZeneca

4:30 - 4:40 p.m.

Closing remarks; Pitch Competition Announcement; Thank you!

In-Person Event Location

FNL Advanced Technology Research Facility
8560 Progress Drive
Frederick, MD 21701